Sun Pharma’s promoter buys 2.6% stake in Natco Pharma

08 Dec 2011 Evaluate

Sun Pharmaceutical Industries’ promoter Dilip Shanghvi has bought a minority stake in Natco Pharma for 18.34 crore. Shanghvi, among the richest men in India, bought Rs 7.25 lakh shares, or 2.6% of Natco Pharma, from Orange Mauritius Investments at Rs 253 apiece. Natco’s promoters and the promoter group own 63% of the company.

Natco Pharma, which employs 2,500 people, has five manufacturing facilities spread across India with dedicated modern research laboratories and capabilities in new drug development. It sells cancer medicines.

Sun Pharmaceutical Industries manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma Inds. Share Price

1466.70 0.00 (0.00%)
27-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1466.70
Dr. Reddys Lab 5875.90
Cipla 1478.35
Zydus Lifesciences 1060.90
Lupin 1615.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.